7 completed, 1 enrolling by invitation, 1 unknown. 5 Phase 4, 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 3, Enrolling by invitation 1, Unknown 1 |
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Benicar: new trials by email Literature Review of Benicar trials Research Report on Benicar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
| Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension CS-3150, olmesartan medoxomil - Essential Hypertension | Not applicable | Completed | Daiichi Sankyo Co., Ltd. | 40 | 2016-08-01 | 2018-12-21 |
| Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) Olmesartan medoxomil tablets, Antihypertensive medication (per doctor suggestion) - Coronary Atherosclerosis | Phase 4 | Unknown | Chinese PLA General Hospital | 100 | 2014-12-01 | 2015-02-11 |
| Olmesartan Comparison to Losartan in Hypertensive Subjects olmesartan medoxomil, Placebo, losartan potassium - Hypertension | Phase 4 | Completed | Daiichi Sankyo | 941 | 2009-08-01 | 2011-03-09 |
| Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers olmesartan medoxomil, olmesartan medoxomil+probenecid - Drug Interaction of Olmesartan in Healthy Chinese Volunteers | Phase 4 | Completed | Central South University | 12 | 2009-08-01 | 2013-07-25 |
| Angiotensin II Blockade and Inflammation in Obesity Olmesartan medoxomil - Overweight, Obese | Phase 4 | Completed | Virginia Polytechnic Institute and State University | 20 | 2009-02-01 | 2018-01-03 |
| Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide - Hypertension | Phase 3 | Completed | Daiichi Sankyo | 2500 | 2008-05-01 | 2019-01-09 |
| Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension Azilsartan Medoxomil, Olmesartan, Placebo - Hypertension | Phase 2 | Completed | Takeda | 449 | 2006-05-01 | 2011-04-19 |
| Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance Aspirin, Alpha lipoic acid, Olmesartan - Impaired Glucose Tolerance, Prediabetic State | Not applicable | Completed | Emory University | 84 | 2005-05-01 | 2013-12-05 |
Hypertension (4) · Diabetes Mellitus (2) · Albuminuria (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1) · Essential Hypertension (1) · Glucose Intolerance (1) · Hyperkalemia (1) · Obesity (1) · Overweight (1) · Prediabetic State (1) · Prehypertension (1) · Renal Insufficiency, Chronic (1)
Daiichi Sankyo (2) · Baylor Research Institute (1) · Central South University (1) · Chinese PLA General Hospital (1) · Daiichi Sankyo Co., Ltd. (1) · Emory University (1) · Takeda (1) · Virginia Polytechnic Institute and State University (1)
United States (5) · China (2) · Argentina (1) · Japan (1) · Mexico (1) · Peru (1) · Puerto Rico (1)
Chen Yundai (1) · Kevin P. Davy, Ph.D. (1) · Kunyan Li, phD (1) · Mary K Rhee, MD, MS (1) · Nong Yang, MS (1)
PMID 19751459, PMID 20678674, PMID 22763801, PMID 22799613, PMID 23110471, PMID 25067982, PMID 26739013
K23DK070715 (1), UL1RR025008 (1)